Assessing the role of immune system in cancer progression from minimal residual disease

被引：1
作者：
Raj, A. Thirumal [1 ]
Patil, Shankargouda [2 ]
Rajkumar, Chandini [3 ]
Sarode, Sachin [4 ]
机构：
[1] Sri Venkateswara Dent Coll & Hosp, Dept Oral Pathol & Microbiol, Madras 600130, Tamil Nadu, India
[2] Jazan Univ, Div Oral Pathol, Coll Dent, Dept Maxillofacial Surg & Diagnost Sci, Jazan, Saudi Arabia
[3] Seminary Med Inquest Adv, Bangalore, Karnataka, India
[4] Dr DY Patil Vidyapeeth, Dr DY Patil Dent Coll & Hosp, Dept Oral Pathol & Microbiol, Pune, Maharashtra, India
来源：
ORAL ONCOLOGY | 2017年 / 75卷
关键词：
T-CELL THERAPY; TUMOR RELAPSE; HETEROGENEITY; VIROTHERAPY; RECURRENCE; MECHANISMS; DORMANCY; ESCAPE;
D O I：
10.1016/j.oraloncology.2017.10.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：180 / 181
页数：2
相关论文
共 13 条
[1]   Models, mechanisms and clinical evidence for cancer dormancy [J].
Aguirre-Ghiso, Julio A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :834-846
[2]   Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse [J].
Boisgerault, Nicolas ;
Kottke, Timothy ;
Pulido, Jose ;
Thompson, Jill ;
Diaz, Rosa Maria ;
Rommelfanger-Konkol, Diana ;
Embry, Addie ;
Saenz, Dyana ;
Poeschla, Eric ;
Pandha, Hardev ;
Harrington, Kevin ;
Melcher, Alan ;
Selby, Peter ;
Vile, Richard .
MOLECULAR THERAPY, 2013, 21 (08) :1507-1516
[3]   Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].
Gerlinger, Marco ;
Rowan, Andrew J. ;
Horswell, Stuart ;
Larkin, James ;
Endesfelder, David ;
Gronroos, Eva ;
Martinez, Pierre ;
Matthews, Nicholas ;
Stewart, Aengus ;
Tarpey, Patrick ;
Varela, Ignacio ;
Phillimore, Benjamin ;
Begum, Sharmin ;
McDonald, Neil Q. ;
Butler, Adam ;
Jones, David ;
Raine, Keiran ;
Latimer, Calli ;
Santos, Claudio R. ;
Nohadani, Mahrokh ;
Eklund, Aron C. ;
Spencer-Dene, Bradley ;
Clark, Graham ;
Pickering, Lisa ;
Stamp, Gordon ;
Gore, Martin ;
Szallasi, Zoltan ;
Downward, Julian ;
Futreal, P. Andrew ;
Swanton, Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892
[4]   Adoptive Transfer of Cytotoxic T Lymphocytes Targeting Two Different Antigens Limits Antigen Loss and Tumor Escape [J].
Kaluza, Karen M. ;
Kottke, Timothy ;
Diaz, Rosa Maria ;
Rommelfanger, Diana ;
Thompson, Jill ;
Vile, Richard .
HUMAN GENE THERAPY, 2012, 23 (10) :1054-1064
[5]   Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants [J].
Kaluza, Karen M. ;
Thompson, Jill M. ;
Kottke, Timothy J. ;
Gilmer, Heather C. Flynn ;
Knutson, Darlene L. ;
Vile, Richard G. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) :844-854
[6]  
Kottke T, 2017, CANC IMMUNOL RES
[7]   Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence [J].
Kottke, Timothy ;
Boisgerault, Nicolas ;
Diaz, Rosa Maria ;
Donnelly, Oliver ;
Rommelfanger-Konkol, Diana ;
Pulido, Jose ;
Thompson, Jill ;
Mukhopadhyay, Debabrata ;
Kaspar, Roger ;
Coffey, Matt ;
Pandha, Hardev ;
Melcher, Alan ;
Harrington, Kevin ;
Selby, Peter ;
Vile, Richard .
NATURE MEDICINE, 2013, 19 (12) :1625-1631
[8]   Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy [J].
Kottke, Timothy ;
Chester, John ;
Ilett, Elizabeth ;
Thompson, Jill ;
Diaz, Rosa ;
Coffey, Matt ;
Selby, Peter ;
Nuovo, Gerard ;
Pulido, Jose ;
Mukhopadhyay, Debabrata ;
Pandha, Hardev ;
Harrington, Kevin ;
Melcher, Alan ;
Vile, Richard .
MOLECULAR THERAPY, 2011, 19 (10) :1802-1812
[9]   Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice [J].
Kottke, Timothy ;
Hall, Geoff ;
Pulido, Jose ;
Diaz, Rosa Maria ;
Thompson, Jill ;
Chong, Heung ;
Selby, Peter ;
Coffey, Matt ;
Pandha, Hardev ;
Chester, John ;
Melcher, Alan ;
Harrington, Kevin ;
Vile, Richard .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (05) :1551-1560
[10]   Intra-tumour heterogeneity: a looking glass for cancer? [J].
Marusyk, Andriy ;
Almendro, Vanessa ;
Polyak, Kornelia .
NATURE REVIEWS CANCER, 2012, 12 (05) :323-334
12